Increasing diversity and equity in clinical trials will require buy-in and commitment from all stakeholders in the research enterprise. In this episode, Colleen Lewis, MSN, ANP-BC, AOCNP, talks about the critical role oncology advanced practitioners can play in moving the needle on equity and inclusion in cancer clinical trials.
In spring 2021, ACCC and Harborside hosted a Virtual Summit to Define on the Role Oncology Advanced Practitioners in Equitable Cancer Care Delivery. Each summit session focused one specific domain of care delivery—Care Coordination and Communication; Clinical Trials; and Acknowledging and Mitigating Implicit Bias. Look for more on the Summit findings coming soon to the ACCC website.
Guest:
Colleen Lewis, MSN, ANP-BC, AOCNP
Director of Clinical Operations, Phase I Program;
Interim Director, Infusion Center Clifton
The Winship Cancer Institute of Emory University
Related Content:
ACCC Community Oncology Research Institute
ASCO-ACCC Initiative to Increase Racial and Ethnic Diversity in Clinical Trials
Real World Lessons from COVID-19 [Video Podcast]
Ep 52: End of Life Disparities [Podcast]
Ep 51: Cultural Humility and Sensitivity [Podcast]
Ep 49: Building Trust with Marginalized Groups [Mini-Podcast]
In Pursuit of Equity: Diversity in Clinical Research Participation [Webinar]
Practical Solutions to Better Engage Cancer Professionals with Communities of Color [Webinar]
Implementation of a Health Disparities & Equity Program at the Duke Cancer Institute,
Paving the Way for APPs in Clinical Research
[Abstract 95] Role of Oncology Advanced Practitioners to Enhance Clinical Research
Research Review: Making Clinical Trials More Inclusive, Diverse, Accessible, and Representative
Phase 1 Clinical Trials in the Elderly: Enrollment Challenges
Bias and stereotyping among research and clinical professionals: perspectives on minority recruitment for oncology clinical trials
